-- The global blood culture test device market is expected to witness lucrative growth in 2016. Demand for blood culture tests is being driven by the rising need for rapid diagnostic techniques. Fast-growing geriatric population and higher incidences of infectious diseases is creating market demand.
Browse Full Research Report With TOC on https://www.radiantinsights.com/research/global-blood-culture-test-device-market-professional-survey-report-2016
Blood stream infections cause serious ailments such as pelvic inflammatory disease, puerperal fever, pneumonia, etc. Patients are increasingly becoming aware of the benefits of early diagnostics. Latest technologies including molecular method, multiplex real-time PCR system, mass spectrometry, electro spray ionization, etc. are gaining popularity. This coupled with high number of product approvals and launches are favoring market growth.
Governments across the world are implementing initiatives in the healthcare space. They are deploying higher funds for development of superior healthcare systems. Moreover, a large customer base exists in the poorly-penetrated developing economies. These factors are foreseen to have a positive effect on growth in 2016.
However, high costs associated with advanced techniques and lack of sufficient reimbursement coverage could prove to be detriment. Key categories of blood culture test devices encompass PCR (Polymerase Chain Reaction), PNA FISH (Peptide Nucleic Acid Probes Fluorescence in Situ Hybridization), blood culture analyzers, & MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization – Time of Flight Mass Spectrometry).
Request A Sample Copy Of This Report at: https://www.radiantinsights.com/research/global-blood-culture-test-device-market-professional-survey-report-2016/request-sample
Blood culture tests may be automated or manual. Applications include aerobic blood culture, anaerobic blood culture, and yeast/fungi blood culture. Hospitals, clinical, academic research, and laboratories constitute the chief end-user fragments.
The global blood culture test device market is split into the following regional segments – South America, USA, Europe, China, Japan, & Africa. USA was a dominant market in the recent past. This is attributed to its sophisticated healthcare establishment, and highly aware consumers. USA is home to innovative technologies like mass spectrometry, Bac Spectrum assay, electro-spray ionization, etc. Its Affordable Care Act supports adoption of blood culture test devices.
Asia Pacific is poised to be a significant participant in the global arena. It will experience accelerated growth in the coming years. Rising product availability, economic growth, and a rapidly-developing healthcare industry will boost consumption of blood culture test devices in this region. The worldwide market is highly competitive. Leading global players comprise Abbott Laboratories, Roche Diagnostics, Bruker Corporation, & Thermo Fisher Scientific Inc.
See More Reports of This Category by Radiant Insights: https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Contact Info:
Name: Michelle Thoras
Email: Send Email
Organization: Radiant Insights, Inc.
Address: 28 2nd Street, Suite 3036 San Francisco
Phone: 4153490054
Website: https://www.radiantinsights.com/research/global-blood-culture-test-device-market-professional-survey-report-2016
Release ID: 123457
Google
RSS